Gastroenterology
Volume 94, Issue 4 , Pages 1089-1091 , April 1988

Colon cancer in ulcerative colitis

  • David F. Ransohoff, M.D.

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: David F. Ransohoff, M.D., Associate Professor of Medicine and Epidemiology, Yale University School of Medicine, P. O. Box 3333, New Haven, Connecticut 06510.
    • Dr. Ransohoff is a Henry J. Kaiser Family Foundation Faculty Scholar in General Internal Medicine.

References 

  1. Whelan G. Cancer risk in ulcerative colitis: why are results in the literature so varied?. Clin Gastroenterol. 1980;9:469–476
  2. Katzka I, Brody RS, Morris E, Katz S. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology. 1983;85:22–29
  3. Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB. Cancer surveillance in ulcerative colitis: experience over 15 years. Lancet. 1983;ii:149–152
  4. Lennard-Jones JE. Cancer risk in ulcerative colitis: surveillance or surgery. Br J Surg. 1985;72:S84–S86 (Suppl)
  5. Collins RH, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. N Engl J Med. 1987;316:1654–1658
  6. Kewenter J, Ahlman H, Kulten L. Cancer risk in extensive ulcerative colitis. Ann Surg. 1978;188:824–828
  7. Gilat T, Fireman Z, Grossman A, et al.  Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology. 1988;94:870–877
  8. Morson BC, Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut. 1967;8:423–434
  9. Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer: problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum. 1985;28:383–388
  10. Lennard-Jones JE. Compliance, cost, and common sense limit cancer control in colitis. Gut. 1986;27:1403–1407
  11. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978;299:926–930
  12. Blackstone MO, Riddell RH, Rogers BHG, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology. 1981;80:366–374
  13. Lennard-Jones JE, Morson BC, Ritchie JK, Shove DC, Williams CB. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology. 1977;73:1280–1289
  14. Riddell RH, Goldman H, Ransohoff DF, et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931–966
  15. Hill MJ, Melville DM, Lennard-Jones JE, Neale K, Ritchie JK. Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis. Lancet. 1987;ii:185–186

PII: 0016-5085(88)90573-2

Gastroenterology
Volume 94, Issue 4 , Pages 1089-1091 , April 1988

Article Tools